Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2014-08-21

CMDh endorses restricted use of bromocriptine for stopping breast milk production

View source ↗

Summary

The CMDh endorses restricted use of bromocriptine (for stopping breast milk production) due to safety concerns and recommends limiting its use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromocriptine (bromocriptine)